BAILEY POLLOCK: Open Payments
NPI 1437871571 · LITTLE ROCK, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,992 in 97 payments from 16 companies in 2025. Trend: 2023 $3,293 · 2024 $3,282 · 2025 $1,992
Food & beverage: $1,893Education: $100
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 11 | $437 |
| ABBVIE INC. | 16 | $283 |
| Lilly USA, LLC | 7 | $234 |
| UCB, Inc. | 18 | $228 |
| E.R. Squibb & Sons, L.L.C. | 11 | $135 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 6 | $131 |
| GENZYME CORPORATION | 4 | $95 |
| LEO Pharma Inc. | 4 | $91 |
| Novartis Pharmaceuticals Corporation | 5 | $82 |
| Regeneron Healthcare Solutions, Inc. | 3 | $74 |
Products named: TREMFYA, Bimzelx, RINVOQ, DUPIXENT, Sotyktu, SKYRIZI, EBGLYSS, TALTZ.
Industry payments across AR — which companies pay providers there.
